drugset / Trial / NCT00956371
ONO-7746 Study in Healthy Adult Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective of this study is to evaluate the safety and tolerability of ONO-7746 in healthy adult subjects. The secondary objectives are to characterize the pharmacokinetic and pharmacodynamic profiles of ONO-7746.
Timeline
- Start
- 2009-08
- Primary completion
- 2010-03
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ONO-7746 | Unknown | 5 mg | — |
| Subject | ONO-7746 | Unknown | 10 mg | — |
| Subject | ONO-7746 | Unknown | 20 mg | — |
| Subject | ONO-7746 | Unknown | 50 mg | — |
| Subject | ONO-7746 | Unknown | 100 mg | — |
| Subject | ONO-7746 | Unknown | 200 mg | — |
| Subject | ONO-7746 | Unknown | 400 mg | — |
| Subject | ONO-7746 | Unknown | 800 mg | — |
| Subject | ONO-7746 | Unknown | 1200 mg | — |
Indications
No indication recorded.